| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9312800 | Urology | 2005 | 6 Pages |
Abstract
These results suggest that HF10, a novel oncolytic HSV-1 mutant, is a promising agent for the treatment of superficial bladder cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Shin-ichi Kohno, Chenhong Luo, Fumi Goshima, Yukihiro Nishiyama, Tetsutaro Sata, Yoshinari Ono,